Related Experiment Video
Updated: Jun 15, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
[Hypofractionated postoperative radiotherapy for breast cancer]
P A Coucke1, N Jansen, J Collignon
1Service de Radiothérapie, CHU de Liège, Belgique. pcoucke@chu.ulg.ac.be
Revue Medicale De Liege
|March 13, 2010
Summary
Hypo-fractionated radiotherapy schedules for breast cancer offer similar local control and reduced toxicity compared to standard treatments. This approach aims to lessen the burden on patients and radiotherapy departments facing increased workloads.
Area of Science:
- Oncology
- Radiotherapy
- Medical Physics
Background:
- Standard postoperative adjuvant radiotherapy for breast cancer involves 25 fractions of 2 Gy to the whole breast plus a boost dose.
- Radiotherapy departments face increasing workloads, necessitating more efficient treatment approaches.
Purpose of the Study:
- To evaluate hypo-fractionated radiotherapy schedules as an alternative to standard treatment for breast cancer.
- To reduce the workload for patients and radiotherapy departments while maintaining treatment efficacy.
Main Methods:
- Review and validation of hypo-fractionated treatment schedules through randomized controlled trials.
- Development of a new treatment algorithm based on evidence from these trials.
Main Results:
- Hypo-fractionated schedules provide comparable local control to standard radiotherapy.
- These schedules demonstrate a similar or lower risk of toxicity compared to conventional fractionation.
Conclusions:
- Hypo-fractionated radiotherapy is a viable and effective alternative for breast cancer treatment.
- This approach can help manage increasing demands on radiotherapy services without compromising patient outcomes.
